共 13 条
- [1] Reply to ‘Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting’ Prostate Cancer and Prostatic Diseases, 2018, 21 : 446 - 447
- [5] Reply to Letter to the Editor re: ‘Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting’ Prostate Cancer and Prostatic Diseases, 2018, 21 : 604 - 604
- [7] Second Reply to Letter to the Editor re: “Clinical utility of the Prostate Health Index (phi) for biopsy decision management in a large group urology practice setting” Prostate Cancer and Prostatic Diseases, 2019, 22 : 639 - 640
- [8] DOES PHYSICIAN PATHOLOGY LAB OWNERSHIP LEAD TO OVERUTILIZATION? A STUDY OF THE EFFECT OF PHYSICIAN OWNERSHIP ON PROSTATE BIOPSY PRACTICE PATTERNS IN A LARGE URBAN UROLOGY GROUP PRACTICE JOURNAL OF UROLOGY, 2013, 189 (04): : E508 - E509
- [10] CLINICAL UTILITY OF PHI (PROSTATE HEALTH INDEX) IN MEN WITH TPSA > 10 NG/ML. RESULTS FROM A MULTICENTRIC EUROPEAN STUDY JOURNAL OF UROLOGY, 2016, 195 (04): : E9 - E9